Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis

被引:110
作者
Benedetto, Umberto [1 ]
Melina, Giovanni
Takkenberg, Johanna J. M. [2 ]
Roscitano, Antonino
Angeloni, Emiliano
Sinatra, Riccardo
机构
[1] Univ Roma La Sapienza, Dept Cardiac Surg, Sch Med 2, Policlin S Andrea, Rome, Italy
[2] Erasmus Univ, Dept Cardiothorac Surg, Med Ctr, Rotterdam, Netherlands
关键词
VALVE-SPARING OPERATIONS; LIFE EXPECTANCY; ASCENDING AORTA; REPLACEMENT; REIMPLANTATION; GUIDELINES; SURGERY;
D O I
10.1136/hrt.2010.210286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Surgical treatment of aortic root aneurysm in Marfan syndrome (MFS) patients. Objective To compare results of total root replacement versus valve-sparing aortic root replacement in MFS patients. Data Sources PubMed, Embase and Cochrane library were searched from January 1966 until February 2010 looking for papers reporting on aortic root operations in MFS patients. 530 studies were retrieved. Study Selection Finally, 11 publications were enrolled. Inclusion criteria were observational studies reporting valve-related morbidity and mortality after total root replacement (TTR) and/or valve-sparing root replacement (VSRR) in patients with MFS and study size n >= 30, reflecting the centre's experience. Data Extraction Data obtained from papers reporting both TRR and VSRR cohorts were analysed separately. In case of multiple publications, the most recent and complete report was selected. If the total number of patient-years was not provided, we calculated it by multiplying the number of hospital survivors with the mean follow-up duration of that study. Results Overall, 1385 patients were analysed (972 patients had TTR and 413 patients had VSRR). Reintervention rate was 0.3%/year (95% CI 0.1 to 0.5) versus 1.3%/year (95% CI 0.3 to 2.2) (p=0.02) and thromboembolic events rate was 0.7%/year (95% CI 0.5 to 0.9) versus 0.3%/year (95% CI 0.1 to 0.6) (p=0.01) after TRR and VSRR, respectively. When composite valve-related events were compared, no difference existed between the two surgical strategies (p=0.41). Among patients undergoing VSRR, reimplantation was associated with a reduced rate of reintervention compared with remodelling (0.7%/year vs 2.4%/year, p=0.02). Conclusions VSRR may represent a valuable option for patients with MFS with aortic aneurysm. However, this technique should be used with caution in patients with valve characteristics at risk for decreased durability.
引用
收藏
页码:955 / 958
页数:4
相关论文
共 21 条
[1]   Guidelines for reporting mortality and morbidity after cardiac valve interventions [J].
Akins, Cary W. ;
Miller, D. Craig ;
Turina, Marko I. ;
Kouchoukos, Nicholas T. ;
Blackstone, Eugene H. ;
Grunkemeier, Gary L. ;
Takkenberg, Johanna J. M. ;
David, Tirone E. ;
Butchart, Eric G. ;
Adams, David H. ;
Shahian, David M. ;
Hagl, Siegfried ;
Mayer, John E. ;
Lytle, Bruce W. .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (04) :523-528
[2]   Aortic root replacement in patients with Marfan's syndrome: The Southampton experience [J].
Alexiou, C ;
Langley, SM ;
Charlesworth, P ;
Haw, MP ;
Livesey, SA ;
Monro, JL .
ANNALS OF THORACIC SURGERY, 2001, 72 (05) :1502-1507
[3]   A TECHNIQUE FOR COMPLETE REPLACEMENT OF ASCENDING AORTA [J].
BENTALL, H ;
DEBONO, A .
THORAX, 1968, 23 (04) :338-&
[4]  
Birks EJ, 1999, CIRCULATION, V100, P29
[5]   Results of aortic valve-sparing operations [J].
David, TE ;
Armstrong, S ;
Ivanov, J ;
Feindel, CM ;
Omran, A ;
Webb, G .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (01) :39-46
[6]   Long-term results of aortic valve-sparing operations in patients with Marfan syndrome [J].
David, Tirone E. ;
Armstrong, Sue ;
Maganti, Manjula ;
Colman, Jack ;
Bradley, Timothy J. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (04) :859-864
[7]   Results of surgery for aortic root aneurysm in patients with Marfan syndrome [J].
de Oliveira, NC ;
David, TE ;
Ivanov, J ;
Armstrong, S ;
Eriksson, MJ ;
Rakowski, H ;
Webb, G .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (04) :789-796
[8]   Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome [J].
Fleischer, KJ ;
Nousari, HC ;
Anhalt, GJ ;
Stone, CD ;
Laschinger, JC .
ANNALS OF THORACIC SURGERY, 1997, 63 (04) :1012-1017
[9]   Replacement of the aortic root in patients with Marfan's syndrome [J].
Gott, VL ;
Greene, PS ;
Alejo, DE ;
Cameron, DE ;
Naftel, DC ;
Miller, DC ;
Gillinov, AM ;
Laschinger, JC ;
Pyeritz, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (17) :1307-1313
[10]   Survival and complication free survival in Marfan's syndrome: implications of current guidelines [J].
Groenink, M ;
Lohuis, TAJ ;
Tijssen, JGP ;
Naeff, MSJ ;
Hennekam, RCM ;
van der Wall, EE ;
Mulder, BJM .
HEART, 1999, 82 (04) :499-504